Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PA-MSHA to reduce postoperative drainage tube indwelling time after mastectomy
ChiCTR2400080213Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2024
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in breast cancer comparing PA-MSHA intervention arm with Placebo control arm (2 arms). Primary endpoints: Cumulative indwelling time of drainage tubes, Daily drainage fluid volume and total drainage fluid volume and 1 more. Planned start Jan 2024; status: not yet recruiting.
02
Drugs
PA-MSHA
03
Conditions
breast cancer
Beyond the preview
Go deeper on ChiCTR2400080213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080213.